Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanomaVaianu Leroy, Anne Pham‐Ledard, Caroline Dutriaux et al.|Cancer Immunology Immunotherapy|2019Cited by 22